BARD J GEESAMAN, M.D.
Osteopathic Medicine in Waltham, MA
License number
Massachusetts 205953
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
55 Black Bear Dr Apartment #1423, Waltham, MA 02451
Phone
(617) 529-7111
Personal information
See more information about BARD J GEESAMAN at radaris.comName
Address
Phone
115 Pacific St, Cambridge, MA 02139
Professional information
See more information about BARD J GEESAMAN at trustoria.com
Dr. Bard J Geesaman, Waltham MA - MD (Doctor of Medicine)
Dr. Bard J Geesaman, Waltham MA - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
55 Black Bear Dr SUITE 1423, Waltham 02451
(617) 529-7111 (Phone)
(617) 529-7111 (Phone)
Certifications:
Internal Medicine, 2000
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Harvard Medical School
Graduated: 1993
Harvard Medical School
Graduated: 1993
Growth-Hormone Secretagogues
Growth-Hormone Secretagogues
US Patent:
2008026, Oct 23, 2008
Filed:
Aug 18, 2005
Appl. No.:
11/573841
Inventors:
Bard J. Geesaman - Waltham MA, US
Assignee:
ELIXIR PHARMACEUTICALS, INC. - Cambridge MA
International Classification:
A61K 38/22, A61K 31/438, A61K 31/404, A61K 31/165, A61K 31/437, A61K 31/4025, A61K 31/7048, A61P 1/00, A61K 31/569, A61K 38/30, A61K 31/4168, A61K 31/407, A61K 31/4412
US Classification:
514 12, 514278, 514418, 514616, 514303, 514422, 514 29, 514325, 514171, 514401, 514415, 514411, 514351
Abstract:
Disclosed are methods of treating a disorder of the stomach, intestine or duodenum in a human subject. The method includes administering to the subject, a pharmaceutical composition comprising a compound that increases gastrointestinal motility (e.g., by modulating myenteric nerve activity) and/or induces the secretion or production of growth hormone.
Combinations Of Metformin And A Meglitinide
Combinations Of Metformin And A Meglitinide
US Patent:
2007016, Jul 19, 2007
Filed:
Nov 7, 2006
Appl. No.:
11/557377
Inventors:
BARD GEESAMAN - Waltham MA, US
International Classification:
A61K 31/155
US Classification:
514635000
Abstract:
Methods of treating glucose related disorders, for example by administering a meglitinide such as mitiglinide, repaglinide, or nateglinide, optionally in combination with a biguanide such as metformin, are described herein.